Drug Trial Radar · NCT04609878
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)
Last checked: Nov 19, 2026Latest source record: Jun 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,274
Actual
Start
Dec 15, 2020
Primary completion
Mar 21, 2025
Study completion Mar 21, 2025
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Oct 30, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma inadequately controlled with standard of care
Conditions
- Asthma
Interventions
BGF MDI 320/28.8/9.6 μgDrug
Budesonide, glycopyrronium, and formoterol fumarate metered dose inhaler
BGF MDI 320/14.4/9.6 μgDrug
Budesonide, glycopyrronium, and formoterol fumarate metered dose inhaler
BFF MDI 320/9.6 μgDrug
Budesonide and formoterol fumarate metered dose inhaler
BFF pMDI 320/9 μgDrug
Budesonide/formoterol fumarate pressurized metered dose inhaler
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in FEV1 AUC0-3 (L) at Week 24Time frame: Week 24
- Pooled (KALOS/LOGOS): Rate of Severe Asthma ExacerbationsTime frame: Up to 52 weeks
Locations
360 sites in 21 countries. Site status is shown where the registry gives one.
Research Site
Saraland, Alabama
Research Site
Phoenix, Arizona
Research Site
Phoenix, Arizona
Research Site
Sun City West, Arizona
Research Site
Tucson, Arizona
Research Site
Tucson, Arizona
Research Site
Little Rock, Arkansas
Research Site
Covina, California
Research Site
Encinitas, California
Research Site
Fresno, California
Research Site
Laguna Hills, California
Research Site
Long Beach, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Mission Hills, California
Research Site
Newport Beach, California
Research Site
Northridge, California
Research Site
San Diego, California
Research Site
Stockton, California
Research Site
Thousand Oaks, California
Research Site
Upland, California
Research Site
Westminster, California
Research Site
Colorado Springs, Colorado
Research Site
Lakewood, Colorado
Research Site
Brandon, Florida
Research Site
Miami, Florida
Research Site
Tampa, Florida
Research Site
Adairsville, Georgia
Research Site
Atlanta, Georgia
Research Site
Columbus, Georgia
Research Site
Lawrenceville, Georgia
Research Site
Rincon, Georgia
Research Site
Savannah, Georgia
Research Site
Tyrone, Georgia
Research Site
Chicago, Illinois
Research Site
River Forest, Illinois
Research Site
Brownsburg, Indiana
Research Site
Indianapolis, Indiana
Research Site
Louisville, Kentucky
Research Site
Crowley, Louisiana
Showing 40 of 360 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.